silence!

Gene Silencing Therapies Could Have Harmful Side Effects, Research Suggests

ScienceDaily (Mar. 26, 2008) — A dramatic new study published in the most recent issue of Nature questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to diabetes.


New kind of gene "silencing" drug works in monkeys

Sector Snap: Gene Silencing
Young Field of Micro-RNA Genetic Research Presents Opportunity for Alnylam, Isis
NEW YORK (Associated Press) - A budding form of genetic research could provide enormous drug development opportunities for several companies, including Alnylam Pharmaceuticals Inc. and Isis Pharmaceuticals Inc., according to a PiperJaffray analyst.